UK biotech Scancell has reported data from a phase 2 trial of its off-the-shelf DNA plasmid vaccine for melanoma that it says backs a swift move to a larger, registrational study. The SCOPE trial of ...
We asked Americans what they’d heard about Trump and Harris throughout the campaign. Here’s what they told us ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback